ArticlePloS one2016

An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.

Jing Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.